CBLIF and neoplasm: Cytokine overexpression through azacitidine’s ability to augment intracellular INF-ɣ increasing macrophage activation and changing the chromatin configuration to increase the transcription of pro-inflammatory genes, helping in tumor control but can cause collateral damage to the surrounding tissues, including the lungs (57, 58).